Mankind Pharma Board to Consider Fund Raising
By Rediff Money Desk, New Delhi Sep 17, 2024 21:55
Mankind Pharma's board will meet this week to discuss raising funds through an issue of securities, including non-convertible debentures, commercial papers, and other debt securities.
New Delhi, Sep 17 (PTI) Mankind Pharma on Tuesday said its board will meet later this week to consider a proposal to raise funds through an issue of securities.
The company's board will meet on September 24 to consider and approve the raising of funds by way of issue of non-convertible debentures, commercial papers, other debt securities or any other security or any combination thereof, the company said in a regulatory filing.
The company, however, did not mention the amount it seeks to raise through the issue of securities.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.
The company in an investor presentation had stated that it looks to grow consumer healthcare business through line extensions, new launches, and premiumization, by leveraging existing brand equity, additional distribution models.
Mankind also looks to increase the value of prescriptions in the existing market and increase the share of chronic segment by growing presence in existing therapies, as per the presentation.
The company's board will meet on September 24 to consider and approve the raising of funds by way of issue of non-convertible debentures, commercial papers, other debt securities or any other security or any combination thereof, the company said in a regulatory filing.
The company, however, did not mention the amount it seeks to raise through the issue of securities.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.
The company in an investor presentation had stated that it looks to grow consumer healthcare business through line extensions, new launches, and premiumization, by leveraging existing brand equity, additional distribution models.
Mankind also looks to increase the value of prescriptions in the existing market and increase the share of chronic segment by growing presence in existing therapies, as per the presentation.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Spicejet Ltd.
- 73.72 ( -5.23)
- 30742139
- Evexia Lifecare
- 3.60 (+ 1.41)
- 29455916
- Bajaj Housing Fin
- 181.48 (+ 9.99)
- 20018481
- Sunshine Capital
- 2.35 ( -2.08)
- 19067530
- Ola Electric Mobilit
- 118.10 (+ 9.71)
- 18600597
MORE NEWS
Rajasthan Seeks UAE Investment: Minister...
Rajasthan's Industry Minister Rathore met with UAE officials in Dubai to attract...
Mankind Pharma Board to Consider Fund Raising
Mankind Pharma's board will meet this week to discuss raising funds through an issue of...
Salesforce Launches Autonomous AI Suite:...
Salesforce introduces Agentforce, an autonomous AI suite for businesses, replacing...